Home / Inspections / 1151595

FDA Inspection 1151595 — Jason Pharmaceuticals, Inc. t/a Medifast

Jason Pharmaceuticals, Inc. t/a Medifast — FEI 1121225

The FDA completed an inspection of Jason Pharmaceuticals, Inc. t/a Medifast on July 20, 2021 in Owings Mills, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 20, 2021
Fiscal Year
2021
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Owings Mills, MD (United States)

Facility

Other inspections at this facility

  • 857606 (NAI Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 792533 (NAI Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 596406 (VAI Mon Jul 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources